How Will the U.S. Glut of Coronavirus Vaccines Affect Manufacturers?

·4-min read

With all the orders for coronavirus vaccines from Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX), Moderna (NASDAQ: MRNA), Johnson & Johnson (NYSE: JNJ), AstraZeneca (NASDAQ: AZN), and Novavax (NASDAQ: NVAX), the U.S. government has more than enough doses to vaccinate the country's entire population. In this video from Motley Fool Live, recorded on April 12, contributors Brian Orelli and Keith Speights discuss what the government might do with those extra doses and the challenges the government faces in giving them away.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting